Pharma Mar, S.A.

MSE:PHM.MC

68.75 (EUR) • At close October 17, 2024
Bedrijfsnaam Pharma Mar, S.A.
Symbool PHM.MC
Munteenheid EUR
Prijs 68.75
Beurswaarde 1,226,438,125
Dividendpercentage 1.84%
52-weken bereik 26.16 - 70.25
Industrie Biotechnology
Sector Healthcare
CEO Mr. Jose Maria Fernandez Sousa-Faro Ph.D.
Website https://www.pharmamar.com

An error occurred while fetching data.

Over Pharma Mar, S.A.

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops

Vergelijkbare Aandelen

Faes Farma, S.A. logo

Faes Farma, S.A.

FAE.MC

3.695 EUR

Fagron NV logo

Fagron NV

FAGR.BR

18.74 EUR

Valneva SE logo

Valneva SE

VLA.PA

2.55 EUR

Arvida Group Limited logo

Arvida Group Limited

ARV.NZ

1.21 NZD

Riverstone Holdings Limited logo

Riverstone Holdings Limited

AP4.SI

0.895 SGD

Vetoquinol SA logo

Vetoquinol SA

VETO.PA

86 EUR

Orpea SA logo

Orpea SA

ORP.PA

12.312 EUR

Uniphar plc logo

Uniphar plc

UPR.IR

2.42 EUR

Dimed S.A. Distribuidora de Medicamentos logo

Dimed S.A. Distribuidora de Medicamentos

PNVL3.SA

10.15 BRL

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)